Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	Oliena Studio Stroke and language recovery: 9000+ videos Español • Italiano • Sardu • English | PDF+

Multiple Sclerosis

Free Subscription Articles published in Lancet Retrieve available abstracts of 12 articles: HTML format Text format

Single Articles

April 2019
1. MCCALL B
   Alemtuzumab to be restricted pending review, says EMA.
   Lancet. 2019;393:1683.
   PubMed     Text format    
   
   
   March 2018
2. METZ LM, Liu WQ
   Effective treatment of progressive MS remains elusive.
   Lancet. 2018;391:1239-1240.
   PubMed     Text format    
   
   
   
3. KAPPOS L, Bar-Or A, Cree BAC, Fox RJ, et al
   Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study.
   Lancet. 2018 Mar 22. pii: S0140-6736(18)30475.
   PubMed     Text format     Abstract available
   
   
   
4. THOMPSON AJ, Baranzini SE, Geurts J, Hemmer B, et al
   Multiple sclerosis.
   Lancet. 2018 Mar 22. pii: S0140-6736(18)30481.
   PubMed     Text format     Abstract available
   
   
   
5. THE LANCET
   End of the road for daclizumab in multiple sclerosis.
   Lancet. 2018;391:1000.
   PubMed     Text format    
   
   
   October 2017
6. GREEN AJ, Gelfand JM, Cree BA, Bevan C, et al
   Clemastine fumarate as a remyelinating therapy for multiple sclerosis (ReBUILD): a randomised, controlled, double-blind, crossover trial.
   Lancet. 2017 Oct 10. pii: S0140-6736(17)32346.
   PubMed     Text format     Abstract available
   
   
   March 2017
7. ATKINS H, Freedman MS
   Immunoablation and aHSCT for aggressive multiple sclerosis - Authors' reply.
   Lancet. 2017;389:908.
   PubMed     Text format    
   
   
   
8. HARRIS M, Cossburn M, Gregory R
   Immunoablation and aHSCT for aggressive multiple sclerosis.
   Lancet. 2017;389:907-908.
   PubMed     Text format    
   
   
   January 2017
9. CHEN H, Kwong JC, Copes R, Tu K, et al
   Living near major roads and the incidence of dementia, Parkinson's disease, and multiple sclerosis: a population-based cohort study.
   Lancet. 2017 Jan 4. pii: S0140-6736(16)32399.
   PubMed     Text format     Abstract available
   
   
   November 2016
10. COMI G, Radaelli M, Soelberg Sorensen P
    Evolving concepts in the treatment of relapsing multiple sclerosis.
    Lancet. 2016 Nov 23. pii: S0140-6736(16)32388.
    PubMed     Text format     Abstract available
    
    
    
11. ONTANEDA D, Thompson AJ, Fox RJ, Cohen JA, et al
    Progressive multiple sclerosis: prospects for disease therapy, repair, and restoration of function.
    Lancet. 2016 Nov 23. pii: S0140-6736(16)31320.
    PubMed     Text format     Abstract available
    
    
    
12. BROWNLEE WJ, Hardy TA, Fazekas F, Miller DH, et al
    Diagnosis of multiple sclerosis: progress and challenges.
    Lancet. 2016 Nov 23. pii: S0140-6736(16)30959.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Multiple Sclerosis is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: